Randomized Trial of the Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages > 6 Months to < 6 Years With Allergic Rhinitis.
Phase of Trial: Phase IV
Latest Information Update: 02 Jul 2015
At a glance
- Drugs Azelastine (Primary)
- Indications Allergic rhinitis
- Focus Adverse reactions
- Sponsors Meda
- 11 Apr 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 25 Jun 2013 New trial record